𝔖 Bobbio Scriptorium

✦ LIBER ✦

PDB25 FIXED COMBINATION METFORMIN PLUS GLIBENCLAMIDE (GLUCOVANCE®) IS COST AND LIFE SAVING COMPARED TO METFORMIN PLUS ROSIGLITAZONE IN TYPE-2 DIABETES PATIENTS IN FRANCE

✍ Scribed by N Cugnardey; S Roze; AJ Palmer; ME Minshall; WJ Valentine; C Renaudin

Book ID: 118607913
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 65 KB
Volume: 8
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)67644-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to Pokharna and Kanna: Initial

Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

✍ A. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Letter to the editor in reference to art

Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes

✍ H. Pokharna; B. Kanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB